SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-049744
Filing Date
2022-08-19
Accepted
2022-08-19 17:02:06
Documents
61
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0622_viveon.htm   iXBRL 10-Q 607012
2 CERTIFICATION f10q0622ex31-1_viveon.htm EX-31.1 10278
3 CERTIFICATION f10q0622ex31-2_viveon.htm EX-31.2 10216
4 CERTIFICATION f10q0622ex32-1_viveon.htm EX-32.1 4155
5 CERTIFICATION f10q0622ex32-2_viveon.htm EX-32.2 4200
  Complete submission text file 0001213900-22-049744.txt   4276579

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE vhaq-20220630.xsd EX-101.SCH 58522
7 XBRL CALCULATION FILE vhaq-20220630_cal.xml EX-101.CAL 25485
8 XBRL DEFINITION FILE vhaq-20220630_def.xml EX-101.DEF 224208
9 XBRL LABEL FILE vhaq-20220630_lab.xml EX-101.LAB 448513
10 XBRL PRESENTATION FILE vhaq-20220630_pre.xml EX-101.PRE 236470
55 EXTRACTED XBRL INSTANCE DOCUMENT f10q0622_viveon_htm.xml XML 480131
Mailing Address C/O GIBSON, DEAL, AND FLETCHER, P. C. 3953 NORCROSS GA 30092
Business Address C/O GIBSON, DEAL, AND FLETCHER, P. C. 3953 NORCROSS GA 30092 4045797978
Viveon Health Acquisition Corp. (Filer) CIK: 0001823857 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39827 | Film No.: 221181495
SIC: 2834 Pharmaceutical Preparations